According to sources, the types of vaccines Nepal will receive have yet to be determined. The COVAX facility has informed the Director of the Family Welfare Division, Dr. Taranath Pokhrel, that AstraZeneca vaccines will be delivered by July. However, the specific delivery date and time have yet to be determined, he noted.
“Nepal has requested 1.5 million doses of AstraZeneca vaccines,” Dr. Pokhrel added, “but the COVAX facility is likely to provide between 350,000 and 1.5 million doses by July.”
COVID-19 Vaccinations Global Access, or COVAX, is a global program led by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the World Health Organization to ensure equitable access to COVID-19 vaccines.
According to The Himalayan Times, the COVAX plant is expected to deliver 1,534,850 doses of Johnson & Johnson’s single-dose Covid-19 vaccine to Nepal.
In a letter to the Department of Drug Administration, the Ministry of Health and Population requested that approval be granted for the import of approximately 1.5 million J&J vaccines via COVAX.
The DDA is the only authority in the country that can authorize the use of Covid-19 vaccines in an emergency. The vaccine will be packed in vials with five doses per vial when it arrives.
After the Serum Institute of India developed COVISHIELD and the Beijing Institute of Biological Product developed Vero cell, this will be the third vaccination used in Nepal.
COVAX, the vaccine pillar of the access to Covid-19 tools (ACT) accelerator, a partnership between CEPI, Gavi, UNICEF, and WHO, had previously committed to providing Nepal with 1,920,000 doses of COVISHIELD by May and had sent 348,000 doses of SII manufactured jabs to Nepal in the first stage on March 07
As of Tuesday, a total of 3,371,761 persons had received coronavirus vaccine across the country, with 2,611,807 of those receiving the first dose and only 759,954 receiving both doses and being fully vaccinated.